StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Merck (MRK) PT Raised to $103 at Truist Securities on Latest Data
October 10, 2022 9:14 AM
Truist Securities analyst Robyn Karnauskas raised the price target on Merck (NYSE: MRK) to $103.00 (from $95.00) while maintaining a ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst PT Change
Hot Comments
Next Articles
Merck (MRK) Shares Rally, Analyst Believes Data Supports Approval of Statercept in PAH
October 10, 2022 11:02 AM